Answers are grounded in this paper and cite their sources.
This meta-analysis, including over a hundred thousand patients, demonstrates a negative association between a higher RMH score and survival in cancer patients. The RMH score holds promise as a readily available prognostic tool across diverse cancer types and clinical settings. Future research should focus on validating and refining this score to aid clinical decision-making.
No takes yet. Share an insight, caveat, or question.
Şahin et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: